Published in J Clin Psychiatry on March 01, 2015
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2016) 0.96
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Can J Psychiatry (2016) 0.84
Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials. Int J Mol Sci (2016) 0.77
Mixed depression: a farewell to differential diagnosis? J Clin Psychiatry (2015) 0.77
"Mixed" depression: drawbacks of DSM-5 (and other) polythetic diagnostic criteria. J Clin Psychiatry (2015) 0.76
Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice. J Neuroinflammation (2016) 0.75
Current irritability associated with hastened depressive recurrence and delayed depressive recovery in bipolar disorder. Int J Bipolar Disord (2016) 0.75
Depression with Mixed Features in Adolescent Psychiatric Patients. Child Psychiatry Hum Dev (2017) 0.75
Longitudinal course and characteristics of cyclothymic disorder in youth. J Affect Disord (2017) 0.75
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry (2007) 8.11
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep (2004) 6.08
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet (2003) 4.79
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep (2008) 3.44
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2004) 3.43
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 3.14
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry (2004) 2.89
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Does long term use of psychiatric drugs cause more harm than good? BMJ (2015) 2.76
A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord (2006) 2.72
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry (2003) 2.69
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry (2003) 2.66
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry (2002) 2.59
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord (2005) 2.58
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry (2005) 2.52
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry (2009) 2.50
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med (2005) 2.42
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
The bipolar spectrum. Br J Psychiatry (2007) 2.36
Culture and assessment of manic symptoms. Br J Psychiatry (2006) 2.35
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry (2006) 2.19
Risk factors for the incidence and persistence of suicide-related outcomes: a 10-year follow-up study using the National Comorbidity Surveys. J Affect Disord (2007) 2.16
Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry (2006) 2.16
Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry (2010) 2.11
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry (2011) 2.10
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01
Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord (2006) 1.99
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Cost of depression in Europe. J Ment Health Policy Econ (2006) 1.96
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2009) 1.96
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases. Health Qual Life Outcomes (2010) 1.94
Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry (2003) 1.94
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry (2009) 1.88
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry (2007) 1.88
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry (2004) 1.86
A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med (2006) 1.82
Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res (2007) 1.77
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol (2009) 1.74
Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemiol Ment Health (2005) 1.73
Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol (2005) 1.73
Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry (2006) 1.72
Growth in early life and childhood IQ at age 11 years: the Newcastle Thousand Families Study. Int J Epidemiol (2005) 1.68
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry (2003) 1.63
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol (2008) 1.60
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord (2009) 1.60
Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord (2007) 1.59
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry (2002) 1.59
The dex/CRH test--is it better than the DST? Psychoneuroendocrinology (2006) 1.59
Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry (2007) 1.57
The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry (2007) 1.57
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry (2005) 1.56
Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry (2005) 1.54
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry (2005) 1.53
The armamentarium of treatments for bipolar disorder: a review of the literature. Int J Neuropsychopharmacol (2006) 1.52
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52
International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry (2004) 1.50
Psychoeducation in bipolar patients with comorbid personality disorders. Bipolar Disord (2004) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Neuropsychological disturbances and cerebral blood flow in bipolar disorder. Aust N Z J Psychiatry (2005) 1.46
QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study. J Clin Psychiatry (2005) 1.46
The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better. J Psychopharmacol (2003) 1.45
Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch Gen Psychiatry (2008) 1.45
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry (2004) 1.44
GABA-ergic drugs: exit stage left, enter stage right. J Psychopharmacol (2003) 1.43
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry (2016) 1.43
Research into putative biological mechanisms of mental disorders has been of no value to clinical psychiatry. Br J Psychiatry (2007) 1.41
Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry (2012) 1.41
The role of dopamine in bipolar disorder. Bipolar Disord (2009) 1.40
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry (2004) 1.39
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry (2002) 1.38
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology (2004) 1.38
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord (2008) 1.37